Literature DB >> 27500276

Number of Primary Care Visits Associated with Screening for Cervical Dysplasia among Women with HIV Infection in Harris County, Texas, United States of America.

Natalie Jm Dailey Garnes1, Gypsyamber D'Souza2, Elizabeth Chiao3.   

Abstract

Studies indicate that women with HIV infection in the United States are inadequately screened for cervical dysplasia. However, few of these studies have included women in the southern United States, where HIV incidence is now concentrated. We performed a retrospective chart review of women with HIV infection in two HIV clinics in a large southern metropolitan area. To describe screening rates among women in care, only women with ≥2 primary care clinic visits during 2007 were included. We used log-binomial regression to estimate prevalence ratios and 95% confidence intervals of screening and to identify demographic, behavioral, and care-related factors associated with screening. Only 52% (258/498) of women in our study were screened during the year; only 29% (8/28) of women with ≤50 CD4 cells/mm3. Factors associated with increased screening in unadjusted analyses included increased number of primary care visits (p<0.001), higher CD4 cell count (p<0.001), younger age (p=0.006) and Hispanic compared to non-Hispanic ethnicity (p<0.001). In adjusted analyses, women with ≥4 primary care visits were 21% more likely to be screened than women with <4 visits (adjusted prevalence ratio = 1.21; 95% confidence interval: 1.02-1.44). Women with CD4 cell counts <200 cells/mm3 were less likely to be screened than women with CD4 counts ≥350 cells/mm3 (adjusted prevalence ratio: 0.77; 95% confidence interval: 0.59- 1.00). Rates of screening for cervical dysplasia were lower than those seen in similar care settings in other geographic areas in the United States. The number of HIV primary care visits, which has been associated with retention in care, was associated with screening prevalence. Interventions designed to improve retention in care may improve screening rates for cervical dysplasia as well.

Entities:  

Keywords:  HIV in women; Pap test; adherence; cervical dysplasia; retention in care

Year:  2015        PMID: 27500276      PMCID: PMC4974513     

Source DB:  PubMed          Journal:  HIV Adv Res Dev        ISSN: 2378-7880


  29 in total

1.  Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002.

Authors:  Steven S Coughlin; Jessica King; Thomas B Richards; Donatus U Ekwueme
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

2.  Papanicolaou testing among women in the southern United States.

Authors:  Neeraja B Peterson; Harvey J Murff; Yong Cui; Margaret Hargreaves; Jay H Fowke
Journal:  J Womens Health (Larchmt)       Date:  2008 Jul-Aug       Impact factor: 2.681

3.  Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States.

Authors:  J E Kaplan; D L Parham; L Soto-Torres; K van Dyck; J A Greaves; K Rauch; B Ellis; H E Amandus
Journal:  J Acquir Immune Defic Syndr       Date:  1999-07-01       Impact factor: 3.731

Review 4.  Factors influencing cervical cancer screening in women infected with HIV: a review of the literature.

Authors:  Crystal L Chapman Lambert
Journal:  J Assoc Nurses AIDS Care       Date:  2012-09-20       Impact factor: 1.354

5.  Cervical cancer screening among HIV-infected women in a health department setting.

Authors:  Jennifer L Logan; Maria Q Khambaty; Karina M D'Souza; Lynette J Menezes
Journal:  AIDS Patient Care STDS       Date:  2010-08       Impact factor: 5.078

6.  Measuring retention in HIV care: the elusive gold standard.

Authors:  Michael J Mugavero; Andrew O Westfall; Anne Zinski; Jessica Davila; Mari-Lynn Drainoni; Lytt I Gardner; Jeanne C Keruly; Faye Malitz; Gary Marks; Lisa Metsch; Tracey E Wilson; Thomas P Giordano
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

7.  Risk factors for nonadherence with Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; C Robert Horsburgh; L Adrienne Cupples; Ann Aschengrau; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-08-31       Impact factor: 2.681

8.  Spectrum of cancer risk late after AIDS onset in the United States.

Authors:  Edgar P Simard; Ruth M Pfeiffer; Eric A Engels
Journal:  Arch Intern Med       Date:  2010-08-09

9.  Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States.

Authors:  Oluwatoyin M Adeyemi; Denis Agniel; Audrey L French; Phyllis C Tien; Kathleen Weber; Marshall J Glesby; Maria C Villacres; Anjali Sharma; Daniel Merenstein; Elizabeth T Golub; William Meyer; Mardge Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

10.  Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic.

Authors:  Faith E Fletcher; Damon J Vidrine; Irene Tami-Maury; Heather E Danysh; Rachel Marks King; Meredith Buchberg; Roberto C Arduino; Ellen R Gritz
Journal:  AIDS Behav       Date:  2014-03
View more
  1 in total

1.  Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system.

Authors:  Arti Barnes; Andrea C Betts; Eric K Borton; Joanne M Sanders; Sandi L Pruitt; Claudia Werner; Andres Bran; Carolee D Estelle; Bijal A Balasubramanian; Stephen J Inrig; Ethan A Halm; Celette Sugg Skinner; Jasmin A Tiro
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.